Tim Beyers

It has been very successful at it for a lot of years, and we offer progeny as a benefit.

And you know what?

I mean, I think we are going to see a lot more of this.

Now, revenue was only up 9.5%.

in the most recent quarter.

But I will say this, gross profit increased 16%, so there's more efficiency here.

It's a profitable company generating cash flow, and this is what I like the most.

that despite all of this uncertainty around healthcare, the client base, so again, self-insured companies expanded to 542 in the most recent quarter, and that was just about 6.75 million members.

So these are covered individuals under progeny.

That's up year over year from 473 clients, which again, self-insured companies, that's a lot.

That's fairly big growth.

The number of covered people underneath that was, again, grew to 6.75 million, up from 6.47 million.

There's clearly a whole bunch of companies that are interested in progeny services because they do have some better indicators and results

for helping those who are having trouble building a family, starting a family.

They're well-known, their principal product is for infertility, and they tend to help those couples who are trying to have a child.

They tend to show clinically better results, and that does show up.

They get chosen more often.

And so this is another piece of this.

They do have other things they're doing.

One of them is they've introduced menopause support and there's strong initial reception for this.